![BCR_ABL1, Female African doctor talking to female patient](/%5E%5Ecdi={43513A8D-0012-473A-A5A1-570018B04076}%5Ehash=/-/media/project/qiagen/qiagen-home/content-worlds/oncology/bcr-abl1-mbcr-testing/s-1257-2-mdx-cg-hero.jpg)
Offer oncologist-hematologists consistency in CML monitoring
BCR::ABL1 Mbcr fusion gene clinical research
When CML research applications require the quantitative detection of BCR::ABL1 Mbcr e14a2 (b3a2) & e13a2 (b2a2)fusion gene transcripts on the IS, our BCR-ABL1 Mbcr RGQ RT-PCR and ipsogen BCR-ABL1 Mbcr IS-MMR kits will deliver.
Browse our region-specific BCR::ABL1 Mbcr tests
In line with established HUGO Gene Nomenclature Committee (HGNC) recommendations for the fusion gene nomenclature (Bruford EA, et al. Leukemia. 2021, https://doi.org/10.1038/s41375-021-01436-6), we are implementing use of italics and double colon (::) for fusion genes designation (e.g. BCR::ABL1). However historical nomenclature (e.g. BCR-ABL1) may persist in our materials.